The group A (N=7) includes samples from health women (control group), according to standard protocol the group B (N=11) includes samples from women diagnosed with preeclampsia, according to recommended by American College of Obstetricians and Gynecologists. ![]() Methods: Placental samples (N=18) were collected after delivery, in a Brazilian reference center of high-risk pregnancy, and were divided in two groups. Objectives: The aim of this study was to evaluate the cyclooxygenase-2 expression in placental tissue from pregnant women diagnosed with preeclampsia. Glauco Ferreira de Oliveira 1 Emily Miranda Nogueira 1 Carolina Foot Gomes de Moura 1,2 Francisco Lazaro Pereira de Sousa 1 Juliana de Carvalho Delgado 1 Renata de Souza Fernandes 3 Andrea Marcelino de Oliveira Juca 1 Luciana Pellegrini Pisani 4 Daniel Araki Ribeiro 4 Sergio Floriano de Toledo 1,5ġCentro Universidade Lusíada, Santos, Brazil 2Pathology, Universidade Federal de São Paulo, Santos, Brazil 3obstetrics, Hospital Guilherme Alvaro, Santos, Brazil 4Universidade Federal de São Paulo, Santos, Brazil 5Obstetrics, Hospital Guilherme Alvaro, Santos, Brazil Theme: AB 1 Maternal Fetal Health/Sub-Theme: AB 1.7 Pre-Eclampsia Health Syndrome ![]() ![]() Cyclooxygenase-2 Analysis in Placental Tissue of Pregnant Women with Preeclampsia
0 Comments
Leave a Reply. |